- Home
- MET vs ALC Comparison
MET vs ALC Comparison
Compare MET & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MET
- ALC
- Stock Information
- Founded
- MET 1863
- ALC 1945
- Country
- MET United States
- ALC Switzerland
- Employees
- MET N/A
- ALC N/A
- Industry
- MET Life Insurance
- ALC Ophthalmic Goods
- Sector
- MET Finance
- ALC Health Care
- Exchange
- MET Nasdaq
- ALC Nasdaq
- Market Cap
- MET 53.2B
- ALC 43.0B
- IPO Year
- MET N/A
- ALC N/A
- Fundamental
- Price
- MET $79.20
- ALC $85.42
- Analyst Decision
- MET Strong Buy
- ALC Buy
- Analyst Count
- MET 12
- ALC 10
- Target Price
- MET $94.17
- ALC $107.00
- AVG Volume (30 Days)
- MET 2.6M
- ALC 1.6M
- Earning Date
- MET 07-30-2025
- ALC 08-19-2025
- Dividend Yield
- MET 2.87%
- ALC 0.39%
- EPS Growth
- MET 112.38
- ALC 6.66
- EPS
- MET 6.14
- ALC 2.25
- Revenue
- MET $73,494,000,000.00
- ALC $9,925,000,000.00
- Revenue This Year
- MET $6.91
- ALC $6.22
- Revenue Next Year
- MET $3.19
- ALC $7.16
- P/E Ratio
- MET $12.87
- ALC $37.41
- Revenue Growth
- MET 8.77
- ALC 3.80
- 52 Week Low
- MET $65.21
- ALC $80.48
- 52 Week High
- MET $89.05
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- MET 53.33
- ALC 40.40
- Support Level
- MET $77.40
- ALC $84.49
- Resistance Level
- MET $79.75
- ALC $89.76
- Average True Range (ATR)
- MET 1.20
- ALC 1.09
- MACD
- MET -0.11
- ALC -0.01
- Stochastic Oscillator
- MET 69.26
- ALC 22.91
About MET MetLife Inc.
MetLife is one of the largest life insurers in the us by assets and provides a variety of insurance and financial-services products. It is organized into five segments: us, Asia, Latin America, Europe/Middle East/Africa, and MetLife Holdings. The us business contributes around 50% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 22% of earnings and is mainly composed of the Japan business, with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of earnings. The EMEA and MetLife Holdings segments contribute around 4% and 11% of earnings, respectively.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.